首页> 外文期刊>Molecular pharmaceutics >Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel
【24h】

Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel

机译:聚酯 - 固体脂质混合纳米颗粒,具有改善的胃肠道稳定性促进了石门素的口服递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The objective of this study was to investigate the role of core stability of nanoparticles on their performances in oral drug delivery. Solid lipids (Geleol Mono and Diglycerides Nf) were incorporated into nanoparticles composed of mPEG-b-PCL by the dialysis method. The prepared solid lipid loaded nanoparticles were found to be spherical nanoparticles with a core state and size distribution dependent on the amount of solid lipid incorporated. The critical aggregation concentrations of lipid-loaded nano particles were determined using pyrene fluorescence. Then, the stability of block copolymer in nanoparticles with different solid lipid contents was studied in simulated gastric fluid and simulated intestinal fluid. Solid lipids were found to stabilize nanoparticle cores by improving not only the thermodynamic stability (lowered CAC) of the nanoparticle but also the chemical stability of the block copolymer in the gastrointestinal environment. The stability of the loaded drug (larotaxel, LTX) in nanoparticles with different solid lipid contents was challenged by intestinal homogenate and rat liver microsome, and solid lipid loaded nanoparticles showed superior drug-protecting capability. Solid lipid incorporation exhibited limited influence on the cytotoxicity and cellular uptake but improved the transcytosis of nanoparticles in Caco-2 monolayers. The results of pharmacokinetic study indicated that core stabilization was helpful in promoting oral larotaxel absorption as the absolute bioavailability of LTX delivered by solid lipid loaded nanoparticles was found to be 13.17%, compared with that by the lipid-free nanoparticles (6.264%) and LTX solution (2.435%). Additionally, the results of biodistribution study indicated relatively higher particle integrity of solid lipid loaded nanoparticles, shown by slower liver and spleen accumulation rate, compared with its lipid-free counterpart. Overall, incorporation of solid lipids made the nanoparticles more suitable for oral drug delivery.
机译:本研究的目的是探讨纳米颗粒的核心稳定性对口服药物递送性能的作用。通过透析方法将固体脂质(Geleol单甘油和碳甘油酯NF)掺入由MPEG-B-PCL组成的纳米颗粒中。发现制备的固体脂质负载的纳米颗粒是具有核心状态和尺寸分布的球形纳米颗粒,其依赖于掺入的固体脂质的量。使用芘荧光测定脂质加载的脂质纳米颗粒的临界聚集浓度。然后,在模拟胃液和模拟肠液中研究了具有不同固体脂质含量的纳米颗粒中嵌段共聚物的稳定性。发现固体脂质通过改善纳米粒子的热力学稳定性(降低CAC),而是在胃肠环境中的嵌段共聚物的化学稳定性,稳定纳米颗粒核心。通过肠匀浆和大鼠肝微粒组攻击具有不同固体脂质含量的纳米颗粒中的装载药物(Larotaxel,LTX)的稳定性,并且固体脂质负载纳米颗粒显示出优异的药物保护能力。固体脂质掺入表现出对细胞毒性和细胞摄取的有限影响,而是改善了CaCo-2单层中纳米颗粒的转红菌菌。药代动力学研究的结果表明,由于固体脂质负载纳米颗粒递送的LTX的绝对生物利用度为13.17%,核心稳定性有助于促进口服门式吸收,而通过无脂质的纳米颗粒(6.264%)和LTX相比,该LTX的绝对生物利用度为13.17%溶液(2.435%)。另外,生物分布研究的结果表明,与其无脂质的对应物相比,通过较慢的肝脏和脾脏累积率表示的固体脂质负载纳米颗粒的粒子完整性相对较高。总体而言,固体脂质的掺入使纳米颗粒更适合口服药物递送。

著录项

  • 来源
    《Molecular pharmaceutics》 |2017年第11期|共12页
  • 作者单位

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Nantong Univ Sch Pharm 19 Qixiu Rd Nantong 226001 Peoples R China;

    Shenyang Pharmaceut Univ Sch Funct Food &

    Wine Dept Wine 103 Wenhua Rd Shenyang 110016;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

    Shenyang Pharmaceut Univ Sch Pharm Dept Pharmaceut 103 Wenhua Rd Shenyang 110016 Liaoning;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    larotaxel; oral drug delivery; mixed nanoparticles; core stability;

    机译:小叶酸;口服药物递送;混合纳米颗粒;核心稳定性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号